2026 Artemetrx State of Specialty Spend and Trend Report
PSG announces the results of the industry’s go-to report on specialty drug spend and trend. With specialty drug costs remaining a top concern…
Read Post
Insights
Categories
Topics
Categories
Topics
Trends in Specialty Drug Benefit Design: New to Market Formulary Blocks
New to market formulary blocks (NTMBs) are increasingly prevalent strategies pharmacy benefit managers (PBMs) are using to control specialty prescription drug costs. NTMBs bar certain newly…
Read Post
Trends in Specialty Drug Benefit Design: Rebates
Employers are navigating a fast-changing landscape of specialty drug benefits. Specialty drug patients now make up 4% of commercially insured member populations as of…
Read Post
2023 Medicare Advantage and Part D Final Rule on Pharmacy Price Concessions
The Centers for Medicare and Medicaid (CMS) published on May 9, 2022, the highly anticipated Medicare Advantage and Part D Final Rule CMS-4192-F. The…
Read Post
How to Apply a Championship Mentality to Critical Pharmacy Priorities
Negotiating an innovative, best-in-class PBM agreement is akin to knocking it out of the park on draft night and free agency. It is critical,…
Read Post
Five Ways to Use Data for a Stronger Pharmacy Strategy
The engine that drives program optimization is integrated pharmacy and medical analytics. Monitoring data is vital and monitoring it across both medical and pharmacy…
Read Post
Q&A: How to Accelerate Plan Performance Review
Today’s pharmacy benefit landscape can feel like a minefield of complex contracts, performance promises, intricate plan designs, and endless benefit considerations. Employers must trust…
Read Post
2022 Trends in Specialty Drug Benefits Report
Overview Over 30% of plan sponsors are exploring alternate models driven mostly by high-cost specialty medications and the need to reduce inappropriate utilization. Right…
Read Post
Member Experience vs. the Great Resignation: Three Moves to Improve UM
What is the point of negotiating stringent contract terms and conditions if no one ensures the rules are followed? Strategic vendor oversight is the…
Read Post
Rare Disease Day Spotlight: Cystic Fibrosis
What is cystic fibrosis? People tend to consider cystic fibrosis (CF) a pediatric disease; however, it can also affect adults. CF is an…
Read Post
Rewriting the Rule Book: Six Things You Need to Accomplish in The RFP Process
Implementation of best-in-class PBM contracting The negotiation process starts with the bid. A well-managed procurement sets the expectation that the bidding PBMs will…
Read Post
2022 Trends in Benefit Design Report
Pharmaceutical Strategies Group (PSG) is pleased to present the 2022 Trends in Drug Benefit Design Report, which details traditional (non-specialty) drug benefit trends…
Read Post